高脂血症、血脂水平与青光眼风险的荟萃分析
该荟萃分析纳入评估高脂血症与青光眼、血脂水平与眼压(IOP)以及高脂血症与IOP相关性的研究,发现高脂血症与青光眼风险显著相关(OR=1.37;95%CI=1.16-1.61),且高脂血症患者IOP较非高脂血症患者高0.51 mmHg(95%CI=0.18-0.83),甘油三酯每升高10 mg/dL,IOP增加0.016 mmHg(95%CI=0.009-0.024)。
要点
- 高脂血症与青光眼风险显著相关(OR=1.37;95%CI=1.16-1.61)。
- 高脂血症患者IOP较非高脂血症患者高0.51 mmHg(95%CI=0.18-0.83)。
- 甘油三酯每升高10 mg/dL,IOP增加0.016 mmHg(95%CI=0.009-0.024)。
核心结论
- 高脂血症与青光眼风险增加显著相关。
- 高脂血症及血脂水平升高与IOP升高相关。
研究设计与样本
- 系统检索Embase、Web of Science和PubMed数据库的相关研究进行荟萃分析。
- 采用合并比值比(OR)及95%置信区间(CI)评估高脂血症与青光眼的关联。
- 采用合并均数差评估血脂水平每升高10 mg/dL对应的IOP变化及高脂血症与非高脂血症患者的IOP差异。
主要发现
- 高脂血症与青光眼显著相关(OR=1.37;95%CI=1.16-1.61),研究间存在显著异质性。
- 仅在横断面研究、仅报告高胆固醇血症患者的研究、仅在北美和欧洲进行的研究或仅纳入正常眼压性青光眼(NTG)患者的亚组分析中,高脂血症与青光眼无显著关联。
- 甘油三酯每升高10 mg/dL,IOP增加0.016 mmHg(95%CI=0.009-0.024),研究间异质性明显(P<0.001;I2=92.0%)。
- 总胆固醇和低密度脂蛋白胆固醇(LDL-c)水平均与IOP显著相关。
- 高脂血症患者IOP较非高脂血症患者高0.51 mmHg(95%CI=0.18-0.83)(异质性P=0.001;I2=81.6%)。
临床怎么用
- 在青光眼风险评估中可关注高脂血症及血脂水平。
- 对于高脂血症患者,监测IOP可能有助于发现眼压升高。
局限性
- 研究间存在显著异质性。
- 仅在横断面研究、仅报告高胆固醇血症患者的研究、仅在北美和欧洲进行的研究或仅纳入NTG患者的亚组分析中,高脂血症与青光眼无显著关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Previous studies reported that hyperlipidemia and blood lipid levels were associated with glaucoma, ocular hypertension (OHT), and intraocular pressure (IOP). However, studies aimed at investigating this association have yielded conflicting results. Therefore, to shed light on these inconclusive findings, we performed multiple distinct meta-analyses to clarify the association of hyperlipidemia and blood lipid levels with glaucoma, OHT, and IOP. METHODS: A systematic literature search from Embase, Web of Science, and PubMed was performed to identify relevant studies. To assess the association between hyperlipidemia and glaucoma, we used the pooled odds ratio (OR) with 95% confidence interval (CI). When we assessed the association between blood lipid levels and IOP levels, the pooled mean difference in IOP associated with a 10 mg/dL increase in the blood lipid level was estimated. The pooled difference in IOP was also estimated between patients with and without hyperlipidemia. All the papers that assessed the correlation between hyperlipidemia and glaucoma, between blood lipid levels and IOP levels, and between hyperlipidemia and IOP were included in this meta-analysis. RESULTS: We detected a marked association between hyperlipidemia and glaucoma (OR = 1.37; 95% CI = 1.16-1.61), with significant heterogeneity among studies. However, hyperlipidemia was not significantly associated with glaucoma in our analysis of only cross-sectional studies, studies that reported only on hypercholesterolemia patients, studies that were conducted only in North America and Europe, or studies in which normal-tension glaucoma (NTG) patients were included only in the subgroup analyses. The pooled results showed that an increase of 10 mg/dL in blood triglyceride levels would increase the IOP by 0.016 mm Hg (95% CI = 0.009-0.024), with evident heterogeneity between studies (P < 0.001; I2 = 92.0%). The pooled results showed that the blood total cholesterol and low-density lipoprotein-cholesterol (LDL-c) level both had a significant association with IOP. When compared to the patients with nonhyperlipidemia, those with hyperlipidemia had a significantly higher IOP of 0.51 mm Hg (95% CI = 0.18-0.83) (P = 0.001 for heterogeneity; I2 = 81.6%). CONCLUSIONS: The evidence suggests that hyperlipidemia is significantly associated with an increased risk of glaucoma and that hyperlipidemia and the increased blood lipid levels are associated with increased IOP.
引用
- Wang S, Bao X. Hyperlipidemia, Blood Lipid Level, and the Risk of Glaucoma: A Meta-Analysis. Invest Ophthalmol Vis Sci. 2019. PMID: 30897618. doi:10.1167/iovs.18-25845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。